Dear Basel,

1- Could you kindly clarify what type of users you are referring to? Are they helping you with testing? Or are they real users, using your app as a real product?
Please keep in mind FIWARE Lab is intended only for experimentation and testing. It is not meant to be used for commercial purposes.

2- I think this is a question for the IDM team and the lab team combined. We need to find out if there is indeed such a script but also check if this type of scalability testing is permitted in FIWARE Lab.

Kind regards,

ilknur

From: Basel basel@rowanalytics.com
Sent: Monday, August 17, 2015 2:08 PM
To: rastislav.petras@eai.eu; petrasrastislav@gmail.com; Chulani, Ilknur; fiware-fiadopt-coaching@lists.fi-ware.org; fiware-lab@lists.fi-ware.org; fiware-lab-help@lists.fi-ware.org; fiware-tech-help@lists.fi-ware.org; kate@playgen.com; rebecca@playgen.com; Steve Gardner; Claus Erik Jensen; Marcin Pawlowski; basel@rowanalytics.com
Subject: Urgent enquiry

Dear Sir/Madam,

We are community members of the Fiware Adopt program and working on the project "HealthySwaps". The company name is "Rowanalytics" and we have the following two urgent questions:

1- Our application requires users to register on the Fiware platform in order to be authorized to use the app in which case Fiware creates basic accounts for them.
The problem is that the basic accounts are deleted/wiped out once the trial period has expired and therefore their accounts credentials are lost as a result and they need to register again.
Could you please advise on how to register our users and authorize them to use the app on Fiware without having the above problem?

2- In order to test the scalability of our App we are working on a simulation of about 10,000 virtual users accessing the app, but to do this we need to be able to create basic account automatically on Fiware to see how
our app and Fiware operate on a large scale. Could you please advise on the best way to create users automatically from e.g. a script?

Your earliest response will be greatly appreciated.

Kind regards

–

Basel Yousef
Informatician
E: basel@rowanalytics.com<basel@rowanalytics.com>
T : +44 1865 575170
M: +44 7799 671644
W: www.rowanalytics.com<http://www.rowanalytics.com>
Skype: basbos2007

[cid:image001.jpg@01D0D8F8.245A96B0]

RowAnalytics Ltd Workspace Oxford, 3 King's Meadow, Oxford, OX2 0DP

This electronic mail transmission is intended for the named recipients only. It may contain private and confidential information. If this has come to you in error you must take no action based upon it, nor must you copy it or show it to anyone; please telephone us immediately and return the original to us. We cannot accept any liability for any loss or damage sustained as a result of software viruses. It is your responsibility to carry out such virus checking as is necessary before opening any attachment, which may be included with this message.

Bu mesaj ve ekleri gönderilen kişiye özeldir ve gizli bilgiler içerebilir. Eğer mesajın gönderilmek istendiği kişi değilseniz lütfen kopyalamayınız, başkalarına göndermeyiniz ve göndericiyi bilgilendiriniz. Internet üzerinden gönderilen mesajların güvenli ve hatasız olduğunun garantisi olmadığından Atos grubu mesajın içeriğinden sorumlu tutulamaz. Göndericinin bilgisayarı anti-virüs sistemleri tarafından taranmaktadır, ancak yine de mesajın virüs içermediği garanti edilemez ve gönderici, meydana gelebilecek zararlardan sorumlu tutulamaz.

This e-mail and the documents attached are confidential and intended solely for the addressee; it may also be privileged. If you receive this e-mail in error, please notify the sender immediately and destroy it. As its integrity cannot be secured on the Internet, the Atos group liability cannot be triggered for the message content. Although the sender endeavors to maintain a computer virus-free network, the sender does not warrant that this transmission is virus-free and will not be liable for any damages resulting from any virus transmitted.

Dear Ilknur,

Please find below the clarifications and if you could please respond
accordingly:

1- These are virtual users created with dummy combinations of diseases
and drugs to allow us to test the app, they are not real people and this
is not for commercial purposes, could you please advise on how to do this?

2. We do not expect a heavy testing load - this is not scalability
testing from an infrastructure stress perspective, but to allow us to
understand the predictive performance of our algorithms and the process
of creating new user accounts for our app.
Could the IDM team advise on this?

Kind regards,
Basel

–
Basel Email Sig

Basel Yousef
Informatician

E: basel@rowanalytics.com
T : +44 1865 575170
M: +44 7799 671644
W: www.rowanalytics.com
Skype: basbos2007

*RowAnalytics Ltd * Workspace Oxford, 3 King's Meadow, Oxford, OX2 0DP

This electronic mail transmission is intended for the named recipients
only. It may contain private and confidential information. If this has
come to you in error you must take no action based upon it, nor must you
copy it or show it to anyone; please telephone us immediately and return
the original to us. We cannot accept any liability for any loss or
damage sustained as a result of software viruses. It is your
responsibility to carry out such virus checking as is necessary before
opening any attachment, which may be included with this message.

_______________________________________________
Fiware-tech-help mailing list
Fiware-tech-help@lists.fi-ware.org
https://lists.fi-ware.org/listinfo/fiware-tech-help

Dear IDM team could you kindly comment on the second question? Thanks..